Charles Schwab Investment Management Inc Vanda Pharmaceuticals Inc. Transaction History

Charles Schwab Investment Management Inc

  • $515 Billion
  • Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 596,210 shares of VNDA stock, worth $2.87 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
596,210
Previous 592,737 0.59%
Holding current value
$2.87 Million
Previous $3.35 Million 16.49%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$4.61 - $6.34 $16,010 - $22,018
3,473 Added 0.59%
596,210 $2.8 Million
Q2 2024

Aug 12, 2024
SELL
$3.91 - $6.5 $294,982 - $490,379
-75,443 Reduced 11.29%
592,737 $3.35 Million
Q1 2024

May 08, 2024
BUY
$3.47 - $4.61 $79,986 - $106,265
23,051 Added 3.57%
668,180 $2.75 Million
Q4 2023

Feb 06, 2024
SELL
$3.38 - $4.58 $3,782 - $5,125
-1,119 Reduced 0.17%
645,129 $2.72 Million
Q3 2023

Nov 08, 2023
BUY
$4.28 - $6.57 $34,993 - $53,716
8,176 Added 1.28%
646,248 $2.79 Million
Q2 2023

Aug 09, 2023
BUY
$5.9 - $6.95 $33,718 - $39,719
5,715 Added 0.9%
638,072 $4.2 Million
Q1 2023

May 11, 2023
SELL
$6.18 - $7.99 $201,950 - $261,097
-32,678 Reduced 4.91%
632,357 $4.29 Million
Q4 2022

Feb 13, 2023
BUY
$6.87 - $10.96 $138,629 - $221,161
20,179 Added 3.13%
665,035 $4.91 Million
Q3 2022

Nov 14, 2022
BUY
$9.44 - $11.76 $97,968 - $122,045
10,378 Added 1.64%
644,856 $6.37 Million
Q2 2022

Aug 15, 2022
SELL
$9.31 - $11.84 $418,056 - $531,663
-44,904 Reduced 6.61%
634,478 $6.92 Million
Q1 2022

May 13, 2022
SELL
$10.84 - $16.55 $302,544 - $461,910
-27,910 Reduced 3.95%
679,382 $7.68 Million
Q4 2021

Feb 11, 2022
BUY
$15.69 - $21.14 $1.06 Million - $1.43 Million
67,410 Added 10.53%
707,292 $11.1 Million
Q3 2021

Nov 16, 2021
BUY
$15.35 - $21.27 $1.3 Million - $1.81 Million
84,975 Added 15.31%
639,882 $11 Million
Q2 2021

Aug 16, 2021
BUY
$15.71 - $21.51 $2.26 Million - $3.1 Million
144,050 Added 35.06%
554,907 $11.9 Million
Q1 2021

May 17, 2021
BUY
$13.42 - $20.28 $732,396 - $1.11 Million
54,575 Added 15.32%
410,857 $6.17 Million
Q4 2020

Feb 16, 2021
BUY
$9.77 - $13.81 $16,911 - $23,905
1,731 Added 0.49%
356,282 $4.68 Million
Q3 2020

Nov 13, 2020
SELL
$9.32 - $12.02 $8,602 - $11,094
-923 Reduced 0.26%
354,551 $3.43 Million
Q2 2020

Aug 14, 2020
BUY
$9.66 - $12.02 $260,559 - $324,215
26,973 Added 8.21%
355,474 $4.07 Million
Q1 2020

May 15, 2020
SELL
$7.5 - $16.8 $719,805 - $1.61 Million
-95,974 Reduced 22.61%
328,501 $3.4 Million
Q4 2019

Feb 07, 2020
SELL
$12.38 - $17.47 $1.29 Million - $1.82 Million
-104,103 Reduced 19.69%
424,475 $6.97 Million
Q3 2019

Nov 08, 2019
BUY
$12.27 - $15.79 $905,759 - $1.17 Million
73,819 Added 16.23%
528,578 $7.02 Million
Q2 2019

Aug 09, 2019
BUY
$13.37 - $18.85 $246,636 - $347,725
18,447 Added 4.23%
454,759 $6.41 Million
Q1 2019

May 14, 2019
BUY
$17.59 - $31.05 $1.27 Million - $2.24 Million
72,121 Added 19.8%
436,312 $8.03 Million
Q4 2018

Feb 14, 2019
SELL
$18.97 - $31.47 $816,222 - $1.35 Million
-43,027 Reduced 10.57%
364,191 $9.52 Million
Q3 2018

Nov 13, 2018
BUY
$18.25 - $23.0 $278,841 - $351,417
15,279 Added 3.9%
407,218 $9.35 Million
Q2 2018

Aug 08, 2018
BUY
$13.95 - $19.15 $136,737 - $187,708
9,802 Added 2.57%
391,939 $7.47 Million
Q1 2018

May 07, 2018
SELL
$14.05 - $20.2 $1.4 Million - $2.02 Million
-99,875 Reduced 20.72%
382,137 $6.44 Million
Q4 2017

Jan 17, 2018
BUY
$12.85 - $18.1 $122,023 - $171,877
9,496 Added 2.01%
482,012 $7.33 Million
Q3 2017

Nov 13, 2017
BUY
$15.4 - $18.85 $7.28 Million - $8.91 Million
472,516
472,516 $8.46 Million

Others Institutions Holding VNDA

# of Institutions
161
Shares Held
45.2M
Call Options Held
165K
Put Options Held
33.6K
View Full List

About Vanda Pharmaceuticals Inc.

VNDA Quotes by TradingView
  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $272M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email